路暢科技(002813.SZ):武漢分公司完成工商註銷登記
格隆匯12月17日丨路暢科技(002813.SZ)公佈,公司於2019年8月27日召開了第三屆董事會2019年第二次定期會議,審議通過了《關於註銷深圳市路暢科技股份有限公司武漢分公司的議案》,同意註銷深圳市路暢科技股份有限公司武漢分公司(“武漢分公司”),並辦理工商註銷手續。
近日,公司收到了武漢市市場監督管理局出具的《准予註銷登記通知書》,經核准,武漢分公司准予註銷。截至公告日,武漢分公司的註銷手續已辦理完畢。
武漢分公司的註銷不會對公司業務發展和盈利水平產生重大影響,符合公司未來戰略發展規劃,不存在損害上市公司及股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.